NeuroPace, Inc.

US$12.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NPCEHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (11.24%)
Div yield —
ROE (103.27%)
Medical Devices
Beta (5Y) 1.93
PE TTM —
TSR TTM 25.75%
Mkt cap US$429.1M
ROIC (8.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
11.02%
(50.04%)
Hold 9|9|12|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.21
0.23
0.23
9.08%
14.40%
29.23%
18.96%
Revenue$M
24.66
24.44
25.86
26.06
9.07%
4.51%
6.29%
7.37%
Peers (US$429.1M)
Cap (US$)
PE
436.5M
—
407.9M
—
422.9M
56.84x
Capital
TTM
5Y
10Y
Leveragex
1.946
(0.294)
(0.273)
EBIT/Intx
0.823
0.249
0.262
Own earn%
(57.92)
(41.47)
(43.24)
Sh yield%
32.54
35.70
37.46
Owners
Insiders/Inst%
6.68
48.52
Short interest%
2.75
SBC / revenue%
4.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
9–20
$1 testx
—
Incr. ROIC%
1